Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Institutional Investor > Frazier Life Sciences Management, L.p. > Profile

Instuitional Investor - Frazier Life Sciences Management, L.p.

Fund Profile
Filing Period:
Fund Name: Frazier Life Sciences Management, L.p.
Portfolio Value $2,187,908,599
Top 13F Holdings
Filing Period:
No. Security Ticker Shares Value % Port
1.
Newamsterdam Pharma Company
 16,116,418 $329,903,076 15.08%
2.
Mirum Pharmaceuticals Inc.
 MIRM 6,795,121 $306,120,201 13.99%
3.
Verona Pharma Plc
 VRNA 3,457,850 $219,538,897 10.03%
4.
Arcutis Biotherapeutics Inc.
 ARQT 8,785,284 $137,401,842 6.28%
5.
Bridgebio Pharma Inc.
 BBIO 3,800,457 $131,381,798 6%
Insider Monkey Quarterly Strategy
+373.4% Insider Monkey Quarterly Strategy
+154.9% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
300%
200%
100%
Subscribe Now

Returns since its inception in May 2014 (through February 19th, 2025)